Researchers found that CEM15 renders HIV dead by altering DNA, causing mutations and preventing replication. The virus can subvert this system, enabling it to make numerous mutations and evade the host's defense.
Immerge BioTherapeutics has identified the PERV receptor, a key factor in understanding the safety of xenotransplantation. This breakthrough allows for the development of safer porcine organs for human transplantation, addressing an unmet need in clinical transplantation.
A study using camera pills found that people taking NSAIDs regularly are at increased risk of small intestinal mucosal ulceration and bleeding. The study, which used capsule endoscopy to visualize the entire small intestine, detected erosions in 62% of NSAID users compared to 5% of non-users.
The GSK Drug Discovery and Development Research Grant Program provides funding for innovative research into HIV/AIDS treatments. Researchers will be selected based on the potential importance of their project, originality, and ability to conduct the proposed research.
Researchers discovered that the removal of MTase1, a viral protein, did not impact virus replication rates in tissue culture. This finding suggests that proteins essential to virus function may be more complex than previously thought, with implications for understanding virus behavior and potential applications in pest control.
A new AIDS vaccine strategy has been developed by Emory University researchers and is now moving to human clinical trials. The vaccine, which employs two different components, aims to induce the immune system to recognize HIV's distinguishing features, providing a safer alternative for HIV prevention.
Researchers found a biochemical structure similarity between the Ebola virus outer protein shell and retroviruses carried by birds, suggesting possible bird transmission. This discovery raises health concerns for humans and encourages officials to be vigilant.
Researchers at Purdue University have simplified the outer shell of the Ebola virus, making it easier to produce in a lab and delivering genes to defective cells. This breakthrough could lead to treatments for diseases like cystic fibrosis and lung cancer.
Researchers from the University of Pittsburgh found that KSHV, a known carcinogenic virus, inhibits immune function and causes cancerous cells to grow through a hormone-like substance called vIL-6. This discovery reveals an overlap between the immune system and tumor suppressor pathways targeted by KSHV.
The AIDS and Cancer Specimen Bank at UCSF is expanding its operations with new technologies and a central coordinating office. The bank now serves over one million specimens from around the world, including China, Thailand, and South America.
A team led by Purdue University's David Sanders has developed a promising system to deliver genes to diseased liver and brain cells using a modified Ross River Virus (RRV) as a Trojan horse. This approach avoids the harmful side effects associated with other retroviruses, bringing gene therapy closer to treating human diseases.
Researchers have identified three new genes in a rhesus monkey rhadinovirus with high structural similarity to those in human herpesvirus-8, paving the way for future studies using recombinant viruses. The goal is to develop targeted drug therapies against specific KSHV genes to prevent virus spread and cancer induction.
The University of Maryland Biotechnology Institute has licensed its DNA Bactofection technology to Microscience, enabling the delivery of DNA vaccines for viral diseases and cancers. Microscience will use the technology to develop a range of DNA vaccines, including those for typhoid, travellers' diarrhea, and hepatitis B virus infection.
A new HIV vaccine candidate has shown promising results, targeting a shared characteristic of all HIV strains and generating antibodies that neutralize a wide range of isolates. The complex could serve as a useful model for HIV vaccine development, bringing researchers closer to their goal of developing an effective vaccine.
Researchers at Ohio State University have developed a peptide treatment that inhibits experimental autoimmune encephalomyelitis (EAE) and suppresses the onset of multiple sclerosis-like symptoms. The treatment targets T cells by binding to CD80, preventing their activation and expansion in disease.
Researchers have identified a natural inhibitor of HIV called CEM15, which can stop the virus from replicating. By targeting Vif, a regulatory protein that enables HIV replication, scientists may develop new antiviral treatments.
The ACP Annals Tip Sheet discusses growth hormone deficiency treatment, exercise counseling effectiveness, and West Nile virus prevention strategies. The USPSTF found mixed evidence on exercise counseling's impact on patient activity, while recommending public mosquito control programs for virus prevention.
The new treatment combines antiviral and anti-inflammatory drugs to target the root cause of cold symptoms, not just its symptoms. Researchers found that adding interferon to the treatment increased effectiveness compared to individual medications alone.
Researchers found that nucleic acid testing can identify acute HIV infection in people who are most contagious, missing routine antibody tests. This can help prevent further transmission and improve long-term prognosis for those diagnosed early.
Scientists have discovered a new method to inhibit HIV replication using short interfering RNAs (siRNAs), a type of RNA interference technology. Researchers demonstrated the effectiveness of siRNAs in human cells, showing promise for novel HIV treatments.
A five-year, $14.8 million NIH-funded award will support HIV/AIDS research in China, focusing on epidemiologic and behavioral interventions, pathogenesis of the virus, safety and efficacy of anti-HIV drugs, and vaccine development. The award aims to improve HIV/AIDS treatment and prevention measures in resource-limited countries.
Researchers at Ohio State University identified 14 genes over-expressed and 12 genes under-expressed in lung cells affected by cancer. The study provides new insights into the genetic basis of lung cancer and could lead to earlier detection methods.
Scientists found that viruses causing diverse ailments like AIDS, common cold, and hepatitis share functional traits, linking large groups of viruses. These traits involve replication mechanisms and messenger RNA stages, suggesting a common ancestor among the viruses. The discovery bolsters prospects for broad-spectrum antiviral agents.
Researchers found surprising parallels in RNA virus replication, suggesting a common strategy to kill various viruses. The discovery could lead to more general virus control strategies.
Researchers discovered that hamsters have higher levels of immune cells in their bloodstream during winter months and in response to acute stress. This enhanced immune response helps the animals prepare for potential injury or infection.
A Baylor College of Medicine study found that Helicobacter pylori infection is most common among children under 10, with an estimated 24.5% infected by age 18-23. The average age of first infection was 7.5 years, and over 84% of infected children remained infected during adolescence and young adulthood.
Recent studies confirm presence of SV40 DNA in human lymphoma samples, suggesting possible vaccine-related transmission. The findings have significant implications for understanding cancer development and prevention.
A new study shows that a vaccine based on a chimpanzee adenovirus possesses the immunological strengths of a human adenovirus vaccine without its drawbacks. The vaccine, developed by researchers at The Wistar Institute, has been shown to be effective in mice against rabies and other viruses.
Researchers found that HIV protein Vpr halts infected T cells from dividing, allowing the virus to replicate efficiently. The study uses a new laboratory technique to detect infected cells, providing a potential window into patient outcomes and treatment options.
Researchers at the University of Maryland Biotechnology Institute have identified specific amino acid residues in the Gumboro-causing viruses responsible for their infection and disease development in poultry. This discovery will enable the creation of more effective genetically engineered vaccines to protect against severe outbreaks.
The Howard Hughes Medical Institute has awarded $16.25 million in new grants to 43 outstanding biomedical researchers from Canada and five Latin American countries. The recipients are investigating various biomedical topics, including parasitic diseases and cancer.
A recent analysis of 31 studies found that individuals with HSV-2 infection are twice as likely to contract HIV, with up to half of cases attributed to preceding HSV-2 infection. The study highlights the importance of controlling HSV-2 infection in preventing HIV acquisition.
According to Roger J. Pomerantz, M.D., physicians should treat HIV-infected individuals when their CD4 lymphocyte count is below 350 or their HIV RNA level exceeds 50,000, rather than immediately upon diagnosis.
Researchers at Jefferson Medical College have demonstrated in the laboratory that prostratin can stimulate two main hiding areas in patients with HIV infection who are taking HAART, leading to death of the virus from anti-viral drugs. The work shows promise for a new second-generation approach to eradicate HIV from the body.
Researchers at Gladstone Institute of Virology and Immunology found that HIV's Vpr gene causes the formation of nuclear herniations, disrupting cell division. This disruption enables virus production to increase severalfold, improving HIV's ability to grow and infect new cells.
Researchers found that prion diseases adapt slowly to new species through a prolonged process, making early detection difficult. The study also showed that the disease can spread rapidly in new hosts under specific conditions.
Researchers at the Gladstone Institute have discovered a new pathway that regulates the activity of NF-kB, a protein controlling key inflammatory and immune responses. The study reveals how acetylation and deacetylation control NF-kB's ability to trigger biological processes.
A study found that socially stressed mice were twice as likely to die after infection with a compound than physically stressed mice. The researchers believe social stress intensified the immune response, leading to toxic shock and organ damage.
Researchers at Ohio State University found that social stress makes specific immune cells resistant to corticosterone, a hormone regulating inflammation. This resistance can lead to uncontrolled inflammation, increasing the severity of infections and tissue damage.
Dr. Duane Grandgenett receives nearly a million dollars in grants to study ways of inhibiting HIV replication in humans. He aims to develop an HIV inhibitor targeting the integrase protein, which plays a crucial role in the virus's survival.
Researchers at the University of Maryland Biotechnology Institute have engineered rats to contain the genome of HIV-1, making them a valuable model for studying AIDS-related diseases. The rats develop clinical signs similar to those of AIDS in humans, including neurological abnormalities and organ damage.
Researchers have developed a new HIV vaccine that provides full protection against vaginal transmission of an HIV-like virus. The vaccine combines elements of the successful Sabin oral poliovirus vaccine with genetic fragments of the AIDS virus, triggering a robust immune response.
A team of researchers has developed an experimental HIV-1 vaccine specifically designed to combat the rising HIV epidemic in Nigeria, where the strain is unique and anti-HIV drugs are largely unavailable. The vaccine uses innovative technologies to induce strong antiviral immunity and has shown promising results in preclinical testing.
Researchers found that IL-7 increases in response to declining CD4+ cell counts, a hallmark of HIV disease. This cytokine stimulates the thymus and other immune tissues to produce new T-cells, potentially rebuilding the entire T-cell compartment.
Researchers found a way to grow hepatitis C virus in labs, enabling genetic studies and potential vaccine development. The breakthrough could speed up progress against the disease, which affects 170 million worldwide.
A recent study from Ohio State University found that stress levels can weaken the immune system's response to pneumonia vaccinations. After six months, vaccinated individuals who were highly stressed showed a weaker immune response compared to those with lower stress levels.
A study found that family caregivers of dementia patients experience a decline in immune responses after vaccination, suggesting they may be more susceptible to illnesses like pneumonia and flu. Chronic stress is believed to play a role in this impairment.
Robert C. Gallo and Luc Montagnier receive Spain's top science award for their groundbreaking work on the diagnosis, prevention, and treatment of HIV/AIDS. The Prince of Asturias Award recognizes their originality and relevance to the scientific community.
At the Institute of Human Virology (IHV) conference, scientists from Africa, Caribbean, and US/Europe discussed HIV/AIDS challenges in the developing world. They emphasized the need for more North-South partnerships to address affordable therapies and preventative vaccines.
Leading AIDS researchers, including Robert Gallo and Seth Berkeley, urge a new era of scientific cooperation to accelerate HIV vaccine development. The epidemic affects 40 million people worldwide, and current funding and resources are insufficient.
Researchers at Harvard Medical School are harnessing the longevity of a herpes simplex virus to develop an HIV vaccine. Their live attenuated vaccine has shown promising results in non-human primates, inducing immunity that lasted for months.
A new DNA test developed by the University of Maryland Biotechnology Institute rapidly identifies Pfiesteria piscicida, a toxic marine microbe linked to fish kills and human illness. The test helps predict outbreaks and study the toxin's effects on immune cells in the brain.
Researchers at the Howard Hughes Medical Institute solved the structure of the reovirus core, a double-stranded RNA virus that bears similarity to pathogens such as rotavirus. The study reveals how the core synthesizes, modifies, and exports viral messenger RNA, ultimately leading to viral replication and takeover of host cells.
The Howard Hughes Medical Institute will award $16.25 million in new grants to support research by outstanding scientists in six countries, including Canada and five Latin American nations. The grants will be awarded competitively and range from $50,000 to $90,000 annually.
Researchers found a key cell gene that aids viruses in multiplying by commandeering host cell machinery. This discovery could lead to new therapeutic approaches and antiviral drugs effective against various RNA viruses.
A study from the University of Washington reveals that people unaware of having genital herpes are just as likely to spread the disease, and education can help identify infected individuals. The study found 83% of asymptomatic people shed HSV-2 virus in their genital secretions.
New research suggests that non-mutational gene defects, involving DNA methylation, contribute significantly to the development of cancer. Up to 10% of genes in some tumor types are found to be inactivated by aberrant DNA methylation, suggesting a much larger role for this process than previously thought.
Researchers at Thomas Jefferson University have created a vaccine using a weakened rabies virus to carry an HIV envelope protein into cells, prompting the immune system to produce anti-HIV antibodies. The successful test in mice lends promise to eventually developing a human vaccine against HIV.
Scientists studying amphibian decline are exploring the role of pathogens like iridovirus and chytrid fungus in causing mass extinctions. The project, funded by a $3 million grant, aims to develop an integrative approach combining expertise from various fields.
Researchers have produced the first 3-D structures of poliovirus in the moments after it attaches to and enters a host cell. The structures reveal tiny adjustments in the virus's protein shell that allow it to grab onto its host receptor more tightly.